Pyroglutamyl-asparagine amide normalizes long-term potentiation in rat hippocampal slices.
Lab research · 2004
- What was studied
- Rat hippocampal slices
- Main finding
- Pyroglutamyl-asparagine amide facilitated weakly induced long-term potentiation and countered ethanol-impaired potentiation in rat hippocampal slices. This separate piracetam-inspired dipeptide is not CPG.
Study data at a glance
- Participants or experimental model
- Rat hippocampal slices
- Reported results
- Pyroglutamyl-asparagine amide facilitated weakly induced long-term potentiation and countered ethanol-impaired potentiation in rat hippocampal slices. This separate piracetam-inspired dipeptide is not CPG.
Study limitations and source details
Study limitations
- Preclinical findings do not establish human benefit or safety.
- Abstract only. Full methods and independent replication remain unconfirmed.
Source details
Primary publication metadata and indexed abstract checked via Europe PMC; full methodological review pending.
Abstract reviewed
Sources checked
Citation
Kapai NA, Chepkova AN, Gudasheva TA, Morozova AA, Skrebitskii VG. Pyroglutamyl-asparagine amide normalizes long-term potentiation in rat hippocampal slices. Bulletin of experimental biology and medicine
Study source ↗ · DOI 10.1023/b:bebm.0000048374.18525.2e · Bibliography entry · Link to this summary
Related compounds
CPG & GZK-111
Cycloprolylglycine (CPG) is a naturally occurring cyclic dipeptide formed from proline and glycine. GZK-111 is an experimental linear precursor. CPG has also been measured as a metabolite of Noopept.
Piracetam
A synthetic compound in the racetam family, also known by the brand Nootropil. It appears in neurological research and historical fatigue-related combination studies.